Home › Non-Muscle Invasive Bladder Cancer › Washington › Seattle
Non-Muscle Invasive Bladder Cancer clinical trials in Seattle, WA
4 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
RecruitingObservational study
- University of Washington School of Medicine, Seattle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
RecruitingObservational study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Blue Light Cystoscopy With Cysview® Registry
RecruitingObservational study
- University of Washington Medicine, Seattle
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Philadelphia, PA7 studies
- Birmingham, AL7 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia41 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.